Cellosaurus cell line OV-UL-2 (CVCL

Cross-references
Cell line name	OV-UL-2
Synonyms	OVarian-ULm-2
Accession	CVCL_X963
Resource Identification Initiative	To cite this cell line use: OV-UL-2 (RRID:CVCL_X963)
Sequence variations	Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Unspecified (PubMed=15153938).
Disease	Ovarian carcinoma (NCIt: C4908)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Female
Age at sampling	Age unspecified
Category	Cancer cell line
Publications	PubMed=11242531; DOI=10.1089/10430340150504019 Bruning A., Kohler T., Quist S.R., Wang-Gohrke S., Mobus V.J., Kreienberg R., Runnebaum I.B. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphaVbeta3. Hum. Gene Ther. 12:391-399(2001) PubMed=15153938; DOI=10.1038/sj.cgt.7700727 Quist S.R., Wang-Gohrke S., Kohler T., Kreienberg R., Runnebaum I.B. Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status. Cancer Gene Ther. 11:547-554(2004)
Cell line databases/resources	cancercelllines; CVCL_X963
Encyclopedic resources	Wikidata; Q54936875
Entry history
Entry creation	05-Sep-2014
Last entry update	19-Dec-2024
Version number	10